Objective: We conducted this study to determine whether it is justifiable for transplant centers to reject cadaveric donor organs based on marginal organ quality. There is a growing discrepancy between the demand for renal transplants and the number of transplants conducted. For the many patients on the renal transplant waiting list, this translates into increased dialysis-associated morbidity, mortality and a reduced quality of life. Patients and Methods: In our retrospective analysis, we focused on deceased donor kidneys that had been rejected in other transplant centers because of poor organ quality (111 patients) and then accepted for transplantation at our center, compared with a control group consisting of 343 patients. Results: Cold ischemia time was statistically significantly shorter in the control group (11 vs. 12.5 h, p = 0.005). Also, delayed graft function occurred significantly (p = 0.004) more often in the study group (45.9-30.3%). Parameters regarding perioperative data and recipient outcome did not show significant differences and except for 2 time points at 1 week and 3 months, graft function did not differ either. Conclusions: We propose that acceptance criteria for marginal donor kidneys should be expanded. Centers should reconsider their acceptance criteria in the light of these findings as the results of these transplantations may even be much better if the delay due to reallocation and retransport can be spared.

Keywords:
Poor organ quality, Rejected kidneys, Kidney transplantation, Expanded-criteria donors
1.
United Network for Organ Sharing. http://www.unos.org/data (accessed December 2012).
2.
Wolfe RA, Ashby VB, Milford EL, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725-1730.
3.
Lopez-Navidad A, Caballero F: Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 2003;17:308-324.
4.
Port FK, Bragg-Gresham JL, Metzger RA, et al: Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002;74:1281-1286.
5.
Rosengard BR, Feng S, Alfrey EJ, et al: Report of the crystal city meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002;2:701-711.
6.
Solez K, Axelsen RA, Benediktsson H, et al: International standardization of criteria for the histologic diagnosis of renal allograft rejection: Banff working classification of kidney transplant pathology. Kidney Int 1993;44:411-422.
7.
Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K: Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993;270:1339-1343.
8.
Oniscu GC, Brown H, Forsythe JL: Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol 2005;16:1859-1865.
9.
Ojo AO, Hanson JA, Meier-Kriesche H, et al: Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001;12:589-597.
10.
Pozzoni P, Del Vecchio L, Pontoriero G, Di Filippo S, Locatelli F: Long-term outcome in hemodialysis: morbidity and mortality. J Nephrol 2004;17(suppl 8):S87-S95.
11.
De Jager DJ, Grootendorst DC, Jager KJ, et al: Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009;302:1782-1789.
12.
Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM: Expanded criteria donors for kidney transplantation. Am J Transplant 2003;3(suppl 4):114-125.
13.
Cacho DT, Cusi LI, Pique AA, et al: Elderly donor kidney transplant: factors involved in graft survival. Transplant Proc 2005;37:3690-3692.
14.
Abbadie O, Lobbedez T, Ficheux M, et al: Is clinical judgment a suitable method to select marginal allograft for transplantation? A single centre experience (in French). Nephrol Ther 2009;5:559-567.
15.
Cadillo-Chavez R, Santiago-Delpin EA, Gonzalez-Caraballo Z, et al: The fate of organs refused locally and transplanted elsewhere. Transplant Proc 2006;38:892-894.
16.
Dahmane D, Audard V, Hiesse C, et al: Retrospective follow-up of transplantation of kidneys from ‘marginal' donors. Kidney Int 2006;69:546-552.
17.
Farid S, Aldouri A, Fraser S, et al: Outcomes of kidney grafts refused by one or more centers and subsequently transplanted at a single United Kingdom center. Transplant Proc 2009;41:1541-1546.
18.
Foster CE 3rd, Weng RR, Smith CV, Imagawa DK: The influence of organ acceptance criteria on long-term graft survival: outcomes of a kidney transplant program. Am J Surg 2008;195:149-152.
19.
Lee CM, Scandling JD, Shen GK, Salvatierra O, Dafoe DC, Alfrey EJ: The kidneys that nobody wanted: support for the utilization of expanded criteria donors. Transplantation 1996;62:1832-1841.
20.
Jung GO, Yoon MR, Kim SJ, et al: The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: single-center study. Transplantation Proc 2010;42:705-709.
21.
Singhal AK, Sheng X, Drakos SG, Stehlik J: Impact of donor cause of death on transplant outcomes: UNOS registry analysis. Transplant Proc 2009;41:3539-3544.
22.
Perez Valdivia MA, Gentil MA, Toro M, et al: Impact of cold ischemia time on initial graft function and survival rates in renal transplants from deceased donors performed in Andalusia. Transplant Proc 2011;43:2174-2176.
23.
Mikhalski D, Wissing KM, Ghisdal L, et al: Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 2008;85(suppl 7):S3-S9.
24.
Quiroga I, McShane P, Koo DD, et al: Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006;21:1689-1696.
25.
Fechner G, Pezold C, Hauser S, Gerhardt T, Müller SC: Kidney's nightshift, kidney's nightmare? Comparison of daylight and nighttime kidney transplantation: impact on complications and graft survival. Transplant Proc 2008;40:1341-1344.
26.
Held PJ, Kahan BD, Hunsicker LG, et al: The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med 1994;331:765-770.
27.
Opelz G, Dohler B: Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007;84:137-143.
28.
Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL: Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997;63:968-974.
29.
Gjertson DW: Impact of delayed graft function and acute rejection on kidney graft survival. Clin Transpl 2000:467-480.
30.
Jacobs SC, Cho E, Foster C, Liao P, Bartlett ST: Laparoscopic donor nephrectomy: the University of Maryland 6-year experience. J Urol 2004;171:47-51.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.